Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a high-yield Melphalan synthesis route using L-phenylalanine. Optimized for cost reduction in pharmaceutical manufacturing with superior impurity control.
Novel Hmb protecting group strategy enhances purity and yield for Thymosin Alpha 1 manufacturing ensuring cost reduction and supply chain stability for global buyers.
Patent CN102199103B details an improved L-thyroxine sodium synthesis via oxidative coupling. Enhances yield and purity for reliable pharmaceutical intermediate supply chains.
Novel low-palladium Heck cyclization route for 6-bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one. Reduces cost and waste.
Novel chiral catalytic hydrogenation route for Duvelisib reduces steps and improves safety for reliable API intermediate supply.
Patent CN111378009A reveals a novel solid-phase synthesis for octreotide using aldehyde resin. This method simplifies processing, reduces side reactions, and offers cost-effective manufacturing solutions.
Patent CN103864877A reveals a high-yield Suzuki coupling route for Abiraterone Acetate, offering significant cost reduction and greener manufacturing for pharmaceutical intermediates.
Patent CN112424149B details a novel recycling method for Tipifarnib synthesis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Explore CN1108653A technology for synthesizing hyper-potent paclitaxel analogs. Offers superior solubility and antitumor activity for reliable API intermediate supply chains.
Patent CN102070611A reveals a high-yield, two-step Hantzsch route for amlodipine intermediates, offering significant cost reduction and scalable manufacturing for global API producers.
Novel green route for Sonidegib intermediates via epoxide ring-opening. Eliminates expensive chiral starting materials and reduces wastewater for cost-effective manufacturing.
Novel industrial method for Dasatinib synthesis avoiding palladium catalysts, offering cost reduction and scalable production for pharmaceutical manufacturers.
Patent CN101397323A details a novel chemical synthesis of hydrocortisone from 17-hydroxyl-4,9-diene intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover a novel 3-step synthesis for Lenalidomide intermediates using glutarimide. Achieve high purity and significant cost reduction in pharma manufacturing with scalable routes.
Patent CN114230568B details a high-yield 4-step route for HER2 inhibitor Tucatinib using Pd(acac)2, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Advanced acid addition salt purification method for Olanzapine synthesis. Reduces coloration and dimer impurities for reliable pharmaceutical intermediate supply chains.
Advanced chiral resolution technology for Crizotinib intermediates ensures high purity and cost reduction in API manufacturing for global supply chains.
Discover a novel mild process for Capecitabine synthesis from Furtulon. High purity, scalable route offering significant cost reduction in pharmaceutical manufacturing.
Patent CN109096148B reveals a novel one-pot method for Vorinostat using modified mesoporous silica, offering high purity and simplified supply chain for pharmaceutical manufacturers.
Patent CN102659919A details a cost-effective bortezomib synthesis using (R)-tert-butylsulfinamide, offering high purity and scalable manufacturing for global supply chains.